SB
ALXN

Simmons Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Simmons Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,515
Closed -$278K – 396
2021
Q2 		$278K Hold
1,515
– – 0.02% 337
2021
Q1 		$232K Sell
1,515
-6,203
-80% -$960K 0.02% 339
2020
Q4 		$1.21M Buy
7,718
+10
+0.1% +$1.28K 0.1% 177
2020
Q3 		$882K Sell
7,708
-3,784
-33% -$408K 0.07% 196
2020
Q2 		$1.29M Sell
11,492
-1,200
-9% -$127K 0.11% 165
2020
Q1 		$1.14M Buy
+12,692
New +$1.25M 0.1% 161

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Simmons Bank's ALXN Position: Q3 2021 in Review

Simmons Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,515 shares — an estimated $278K sold.

Simmons Bank first reported a position in ALXN in Q1 2020 and held it in 6 quarters. The position peaked at $1.29M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Simmons Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Simmons Bank sold 1,515 Alexion Pharmaceuticals shares in Q3 2021, an estimated $278K.
  • Simmons Bank first reported a position in Alexion Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Simmons Bank's Alexion Pharmaceuticals position peaked at $1.29M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Simmons Bank's 13F filing for Q3 2021, filed 26 Oct 2021.